Price Target Update on HCP (NYSE:HCP)

HCP (NYSE:HCP) stock is expected to deviate a maximum of $6.26 from the average target price of $31.29 for the short term period. 7 Street Experts have initiated coverage on the stock with the most promising target being $43 and the most muted being $23.

Other Equity analysts have also commented on the company shares. Citigroup maintains its view on HCP (NYSE:HCP) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. Citigroup raises the price target from $31 per share to $34 per share on HCP . The rating by the firm was issued on May 16, 2016.

HCP (NYSE:HCP): stock turned positive on Thursday. Though the stock opened at $34.26, the bulls momentum made the stock top out at $34.62 level for the day. The stock recorded a low of $33.94 and closed the trading day at $34.11, in the green by 0.18%. The total traded volume for the day was 3,734,563. The stock had closed at $34.05 in the previous days trading.

The company shares have dropped -6.30% from its 1 Year high price. On Aug 19, 2015, the shares registered one year high at $40.90 and the one year low was seen on Feb 11, 2016. The 50-Day Moving Average price is $33.93 and the 200 Day Moving Average price is recorded at $33.93. On the companys insider trading activities, The Securities and Exchange Commission has divulged that Hsiao Kai, officer (Executive Vice President) of Hcp, Inc., had unloaded 266 shares at an average price of $36.04 in a transaction dated on May 9, 2016. The total value of the transaction was worth $9,587.

HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.